SCHEMBL313350

SCHEMBL313350

CCOC(=O)Nc1cc(O)cc(O)c1-c1cc(=O)c2cnccc2o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
HPGD P15428 4/20 0.44
HSD17B10 Q99714 3/20 0.44
LMNA P02545 1/20 0.44
ALDH1A1 P00352 2/20 0.40
MAOB P27338 1/20 0.40
CSNK2A2 P19784 2/20 0.38
CSNK2B P67870 2/20 0.38
CSNK2A1 P68400 2/20 0.38
TNKS O95271 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
BRAF P15056 1/20 0.36
EIF2AK3 Q9NZJ5 1/20 0.36
AKR1B1 P15121 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311739 0.92 KDM4E (0.44) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL312060 0.86 HPGD (0.44) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL312706 0.86 KDM4E (0.61) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL311578 0.85 HPGD (0.45) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL313031 0.82 HPGD (0.38) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL312777 0.82 HPGD (0.43) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL312537 0.82 KDM4E (0.39) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL312639 0.80 HPGD (0.44) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL311364 0.78 HPGD (0.44) KDM4EHPGDHSD17B10LMNAALDH1A1
SCHEMBL311551 0.78 HPGD (0.39) KDM4EHPGDHSD17B10LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed